These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34182184)

  • 41. Predictors of Immunotherapy Efficacy in Metastatic Non-Small Cell Lung Cancer: Lung Immune Prognostic Index and Immune-Related Toxicity.
    Moratiel Pellitero A; Zapata Garcia M; Gascon Ruiz M; Arbones-Mainar JM; Lastra Del Prado R; Isla D
    World J Oncol; 2024 Apr; 15(2):223-238. PubMed ID: 38545481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab.
    Nakamura K; Ishiyama Y; Nemoto Y; Ishihara H; Tachibana H; Fukuda H; Shinmura H; Hashimoto Y; Yoshida K; Iizuka J; Ishida H; Kondo T; Takagi T
    Int J Clin Oncol; 2023 Jul; 28(7):913-921. PubMed ID: 37103730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients.
    Mazzaschi G; Minari R; Zecca A; Cavazzoni A; Ferri V; Mori C; Squadrilli A; Bordi P; Buti S; Bersanelli M; Leonetti A; Cosenza A; Ferri L; Rapacchi E; Missale G; Petronini PG; Quaini F; Tiseo M
    Lung Cancer; 2020 Oct; 148():1-11. PubMed ID: 32768804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index.
    Buti S; Bersanelli M; Perrone F; Tiseo M; Tucci M; Adamo V; Stucci LS; Russo A; Tanda ET; Spagnolo F; Rastelli F; Pergolesi F; Santini D; Russano M; Anesi C; Giusti R; Filetti M; Marchetti P; Botticelli A; Gelibter A; Occhipinti MA; Ferrari M; Vitale MG; Nicolardi L; Chiari R; Rijavec E; Nigro O; Tuzi A; De Tursi M; Di Marino P; Conforti F; Queirolo P; Bracarda S; Macrini S; Gori S; Zoratto F; Veltri E; Di Cocco B; Mallardo D; Vitale MG; Santoni M; Patruno L; Porzio G; Ficorella C; Pinato DJ; Ascierto PA; Cortellini A
    Eur J Cancer; 2021 Jan; 142():18-28. PubMed ID: 33212418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between the modified lung immune predictive index and clinical outcomes of advanced non-small cell lung cancer treated with first-line immune checkpoint inhibitors combined with chemotherapy.
    Xu H; Tian W; Lin X; Leong TL; Seki N; Ichiki Y; Su S; Chen J; Li Y; Ye J
    J Thorac Dis; 2023 Nov; 15(11):6279-6290. PubMed ID: 38090322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis.
    Yang T; Hao L; Yang X; Luo C; Wang G; Lin Cai C; Qi S; Li Z
    BMJ Open; 2021 Sep; 11(9):e049123. PubMed ID: 34475167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sixth-Week Immune-Nutritional-Inflammatory Biomarkers: Can They Predict Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors?
    Olgun P; Diker O
    Curr Oncol; 2023 Dec; 30(12):10539-10549. PubMed ID: 38132403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis.
    Tian BW; Han CL; Wang HC; Yan LJ; Ding ZN; Liu H; Mao XC; Tian JC; Xue JS; Yang LS; Tan SY; Dong ZR; Yan YC; Wang DX; Li T
    Clin Exp Metastasis; 2023 Aug; 40(4):255-287. PubMed ID: 37308706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer.
    Sun B; Hou Q; Liang Y; Xue S; Yao N; Wei L; Cao X; Li H; Si H; Cao J
    BMC Cancer; 2022 Nov; 22(1):1233. PubMed ID: 36447193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of the Lung Immune Prognostic Index for HER-2-negative metastatic gastric cancer.
    Gou M; Zhang Y; Qu T; Jia R; Wang Z; Dai G
    Biomark Med; 2023 Sep; 17(17):711-721. PubMed ID: 38085163
    [No Abstract]   [Full Text] [Related]  

  • 51. The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy.
    Obayashi K; Miki J; Fukuokaya W; Yanagisawa T; Kimura S; Tsuzuki S; Kimura T; Egawa S
    Int J Clin Oncol; 2022 Feb; 27(2):396-402. PubMed ID: 34714458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of Lung Immune Prognostic Index With Efficacy of PD-1/PD-L1 Inhibitor Combined With Chemotherapy and Prognosis in Patients With Advanced Non-Small Cell Lung Cancer.
    Zhu Z; Zhang A
    Am J Clin Oncol; 2023 Nov; 46(11):496-502. PubMed ID: 37621004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection.
    Zhou Q; Deng G; Wang Z; Dai G
    Front Surg; 2022; 9():1002075. PubMed ID: 36684178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low baseline plasma PCSK9 level is associated with good clinical outcomes of immune checkpoint inhibitors in advanced non-small cell lung cancer.
    Xie M; Yu X; Chu X; Xie H; Zhou J; Zhao J; Su C
    Thorac Cancer; 2022 Feb; 13(3):353-360. PubMed ID: 34962050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy.
    Ruiz-Bañobre J; Areses-Manrique MC; Mosquera-Martínez J; Cortegoso A; Afonso-Afonso FJ; de Dios-Álvarez N; Fernández-Núñez N; Azpitarte-Raposeiras C; Amenedo M; Santomé L; Fírvida-Pérez JL; García-Campelo R; García-González J; Casal-Rubio J; Vázquez S
    Transl Lung Cancer Res; 2019 Dec; 8(6):1078-1085. PubMed ID: 32010585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors.
    Seban RD; Mezquita L; Berenbaum A; Dercle L; Botticella A; Le Pechoux C; Caramella C; Deutsch E; Grimaldi S; Adam J; Ammari S; Planchard D; Leboulleux S; Besse B
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1147-1157. PubMed ID: 31754795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs).
    Li Y; Zhang Z; Hu Y; Yan X; Song Q; Wang G; Chen R; Jiao S; Wang J
    Front Oncol; 2020; 10():654. PubMed ID: 32656072
    [No Abstract]   [Full Text] [Related]  

  • 58. Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
    Buti S; Bersanelli M; Perrone F; Bracarda S; Di Maio M; Giusti R; Nigro O; Cortinovis DL; Aerts JGJV; Guaitoli G; Barbieri F; Ferrara MG; Bria E; Grossi F; Bareggi C; Berardi R; Torniai M; Cantini L; Sforza V; Genova C; Chiari R; Rocco D; Della Gravara L; Gori S; De Tursi M; Di Marino P; Mansueto G; Zoratto F; Filetti M; Citarella F; Russano M; Mazzoni F; Garassino MC; De Toma A; Signorelli D; Gelibter A; Siringo M; Follador A; Bisonni R; Tuzi A; Minuti G; Landi L; Ricciardi S; Migliorino MR; Tabbò F; Olmetto E; Metro G; Adamo V; Russo A; Spinelli GP; Banna GL; Addeo A; Friedlaender A; Cannita K; Porzio G; Ficorella C; Carmisciano L; Pinato DJ; Mazzaschi G; Tiseo M; Cortellini A
    Eur J Cancer; 2021 Jun; 150():224-231. PubMed ID: 33934059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the Lung Immune Prognostic Index in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy: A Retrospective Study and Meta-Analysis.
    Huang L; Han H; Zhou L; Chen X; Xu Q; Xie J; Zhan P; Chen S; Lv T; Song Y
    Front Oncol; 2021; 11():670230. PubMed ID: 34249708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer.
    Tanaka S; Uchino J; Yokoi T; Kijima T; Goto Y; Suga Y; Katayama Y; Nakamura R; Morimoto K; Nakao A; Hibino M; Tani N; Takeda T; Yamaguchi H; Tachibana Y; Takumi C; Hiraoka N; Takeshita M; Onoi K; Chihara Y; Taniguchi R; Yamada T; Matsui Y; Hiranuma O; Morimoto Y; Iwasaku M; Tokuda S; Kaneko Y; Yamada T; Takayama K
    Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.